The global Hysteroscopy Procedures market gathered revenue around USD 3.7 Billion in 2020 and market is set to grow USD 7.21 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 7.4% during the prediction period 2021 to 2027.
Growth Factors:
The increasing prevalence of gynecological disorders, such as uterine abnormalities, abnormal uterine bleeding, uterine fibroids, and fertility disorders, is a key factor driving the market growth. Moreover, the rising adoption of minimally invasive surgeries over traditional methods and technological advancements are other major factors fueling the market growth.
Surge in prevalence of gynecological disorders, technological advancements, increasing adoption of minimally invasive surgeries, and favorable reimbursement policies are the key driving factors for the market. In addition, the impact of the COVID-19 pandemic has been significant on the market.
The pandemic has affected companies’ ability to develop and commercialize new & advanced products. Almost all companies are affected by reduced procedure volumes due to the pandemic, as all hospital resources are being diverted to fight the disease. Furthermore, the restrictions and functioning of a limited number of government offices are expected to delay clinical trials of products, which is expected to result in delayed product launches by companies.
The increasing prevalence of uterine fibroids is a key factor driving the market. For instance, as per the research article published in Dove Press Ltd., the prevalence of uterine fibroid disease ranges from 5.40% to 24.0%, depending upon the age group. Moreover, uterine fibroids can cause serious problems in 25% of women. Hysteroscopy is used to diagnose abnormalities, such as excessive bleeding, severe stomach cramps, recurrent miscarriages, or difficulties in conceiving. Thus, the presence of such a large patient pool leads to increased demand for hysteroscopy procedures.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Hysteroscopy Procedures market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Hysteroscopy Procedures market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
Report Coverage
Report Scope | Details |
Market Size | USD 7.21 Billion by 2027 |
Growth Rate | CAGR of 7.4% From 2021 to 2027 |
Base Year | 2020 |
Forecast Period | 2021 to 2027 |
Historic Data | 2017 to 2020 |
Report coverage | Growth Factors, Revenue Status, Competitive Landscape, and Future Trends |
Segments Covered | End use And Region |
Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
Companies Mentioned | Medtronic; Stryker Corp.; Hologic, Inc.; KARL STORZ SE & Co. KG; Medical Devices Business Services, Inc. (Ethicon, Inc.); Olympus Corp.; Delmont Imaging; B. Braun Melsungen AG; Richard Wolf GmbH; CooperCompanies; Maxer Endoscopy GmbH; Boston Scientific Corp.. |
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Hysteroscopy Procedures market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
Regional analysis:
North America dominated the global market with a revenue share of over 37.9% in 2020 and will expand further at a steady CAGR from 2021 to 2027. This can be attributed to favorable government regulations & reimbursement policies, the presence of key market players, growing approval & commercialization of products, and high awareness regarding the availability of diagnostic tests & treatments. Furthermore, the rising demand for minimally invasive procedures and increasing investments in the R&D of gynecological systems are among the factors responsible for market growth in the region. For instance, in August 2018, the U.S. FDA approved Luminelle DTx Hysteroscopy System by UVision360 for both hysteroscopy and cystoscopy. The system allows physicians to perform in-office hysteroscopic procedures, such as biopsy, and detect abnormal tissue growth. Thus, the ease of access to healthcare technologies, the presence of strong distribution channels, and competition among prominent players related to product innovation are contributing to market growth in this region.
Asia Pacific is expected to be the fastest-growing regional market during the forecast period. The presence of a large patient pool and the growing need for technologically advanced & cost-effective healthcare solutions are among factors expected to present significant growth opportunities in the market. Moreover, an increase in the number of clinical trials and high R&D investments by global market players to enter untapped markets in Asia Pacific region, owing to low-cost services, are high-impact rendering drivers of the market. Moreover, the rising incidence of diseases related to women’s health and subsequently increasing the number of surgeries are expected to boost the regional market growth over the forecast period. Singapore and South Korea are some of the emerging economies in Asia Pacific. Advancing technology, increasing investments, improving reimbursement scenarios, and growing medical tourism are among the factors expected to drive the region’s growth.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
Some of the prominent players in the Hysteroscopy Procedures Market include: Medtronic; Stryker Corp.; Hologic, Inc.; KARL STORZ SE & Co. KG; Medical Devices Business Services, Inc. (Ethicon, Inc.); Olympus Corp.; Delmont Imaging; B. Braun Melsungen AG; Richard Wolf GmbH; CooperCompanies; Maxer Endoscopy GmbH; Boston Scientific Corp.; MedGyn Products, Inc.; Lina Medical APS; Luminelle; Meditrina, Inc. (Aveta)
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Highlights of the Report:
Research Methodology
In the study, a unique research methodology is utilized to conduct extensive research on the growth of the Hysteroscopy Procedures market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the Hysteroscopy Procedures market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the Hysteroscopy Procedures markets more accurate and reliable.
Secondary Research
It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.
The secondary research sources referred in the process are as follows:
Primary Research
Primary research includes face-to face interviews, online surveys, and telephonic interviews.
Industry participants involved in this research study include:
Key Points Covered in Hysteroscopy Procedures market Study:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Hysteroscopy Procedures Market, By End-use
7.1. Hysteroscopy Procedures Market, By End-use, 2021-2027
7.1.1. Hospitals
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Clinics
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Ambulatory Surgery Centers (ASCs)
7.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Hysteroscopy Procedures Market, Regional Estimates and Trend Forecast
8.1. North America
8.1.1. Market Revenue and Forecast, By End-use (2016-2027)
8.1.2. U.S.
8.1.3. Rest of North America
8.1.3.1. Market Revenue and Forecast, By End-use (2016-2027)
8.2. Europe
8.2.1. Market Revenue and Forecast, By End-use (2016-2027)
8.2.2. UK
8.2.2.1. Market Revenue and Forecast, By End-use (2016-2027)
8.2.3. France
8.2.3.1. Market Revenue and Forecast, By End-use (2016-2027)
8.2.4. Rest of Europe
8.2.4.1. Market Revenue and Forecast, By End-use (2016-2027)
8.3. APAC
8.3.1. Market Revenue and Forecast, By End-use (2016-2027)
8.3.2. India
8.3.2.1. Market Revenue and Forecast, By End-use (2016-2027)
8.3.3. China
8.3.3.1. Market Revenue and Forecast, By End-use (2016-2027)
8.3.4. Japan
8.3.4.1. Market Revenue and Forecast, By End-use (2016-2027)
8.3.5. Rest of APAC
8.3.5.1. Market Revenue and Forecast, By End-use (2016-2027)
8.4. MEA
8.4.1. Market Revenue and Forecast, By End-use (2016-2027)
8.4.2. GCC
8.4.2.1. Market Revenue and Forecast, By End-use (2016-2027)
8.4.3. North Africa
8.4.3.1. Market Revenue and Forecast, By End-use (2016-2027)
8.4.4. South Africa
8.4.4.1. Market Revenue and Forecast, By End-use (2016-2027)
8.4.5. Rest of MEA
8.4.5.1. Market Revenue and Forecast, By End-use (2016-2027)
8.5. Latin America
8.5.1. Market Revenue and Forecast, By End-use (2016-2027)
8.5.2. Brazil
8.5.2.1. Market Revenue and Forecast, By End-use (2016-2027)
8.5.3. Rest of LATAM
8.5.3.1. Market Revenue and Forecast, By End-use (2016-2027)
Chapter 9. Company Profiles
9.1. Medtronic
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. Stryker Corp
9.2.1. Company Overview
9.2.2. Product Offerings
9.2.3. Financial Performance
9.2.4. Recent Initiatives
9.3. Hologic, Inc.
9.3.1. Company Overview
9.3.2. Product Offerings
9.3.3. Financial Performance
9.3.4. Recent Initiatives
9.4. KARL STORZ SE & Co. KG
9.4.1. Company Overview
9.4.2. Product Offerings
9.4.3. Financial Performance
9.4.4. Recent Initiatives
9.5. Medical Devices Business Services, Inc
9.5.1. Company Overview
9.5.2. Product Offerings
9.5.3. Financial Performance
9.5.4. Recent Initiatives
9.6. Olympus Corp.
9.6.1. Company Overview
9.6.2. Product Offerings
9.6.3. Financial Performance
9.6.4. Recent Initiatives
9.7. Delmont Imaging
9.7.1. Company Overview
9.7.2. Product Offerings
9.7.3. Financial Performance
9.7.4. Recent Initiatives
9.8. B. Braun Melsungen AG
9.8.1. Company Overview
9.8.2. Product Offerings
9.8.3. Financial Performance
9.8.4. Recent Initiatives
9.9. Richard Wolf GmbH
9.9.1. Company Overview
9.9.2. Product Offerings
9.9.3. Financial Performance
9.9.4. Recent Initiatives
9.10. CooperCompanies
9.10.1. Company Overview
9.10.2. Product Offerings
9.10.3. Financial Performance
9.10.4. Recent Initiatives
Chapter 10. Research Methodology
10.1. Primary Research
10.2. Secondary Research
10.3. Assumptions
Chapter 11. Appendix
11.1. About Us
11.2. Glossary of Terms